Lifecore Biomedical, Inc.

LFCR

Lifecore Biomedical, Inc. and its subsidiaries ( Lifecore , the Company , we or us ), located in Chaska, Minnesota, is a fully integrated contract development and manufacturing organization ( CDMO ) that offers highly differentiated clinical and commercial capabilities in the development, cGMP manufacturing and aseptic filling of complex formulations and highly viscous sterile injec…

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$244M

EPS–

P/E–

P/FCF–

EV/EBITDA–

FCF Yield–

Div. Yield–

Net Debt/FCF–

Lifecore Biomedical, Inc. intrinsic value

52-Week Range

$3.66$8.82

Profitability & Returns

TTM as of 2026-06 · YoY vs prior year · ROIC = NOPAT / invested capital

Revenue

N/A

Net Income

N/A

Op. Margin

–

ROIC

–

Cash Flow & Balance Sheet

FCF = operating cash flow + capex · Net debt = total debt − cash · Balance sheet from latest filing

FCF

N/A

Op. Cash Flow

N/A

Net Debt

$146M

Cash & Equiv.

$17M

Continue Research

Quality Scorecard

Is this a high-quality business?

Dividends

Payout safety and growth

Intrinsic Value

What is it worth?

Financials

Full income, cash flow, balance sheet

Peers

Pharmaceutical Preparations · Pick stocks to compare with LFCR

CompareIntrinsic value

ASRTAssertio Holdings Inc.

$9.09+0.28%10

TBPHTheravance Biopharma Inc.

No recent price82

XNCRXencor Inc.

$35.01+14.28%0

ETONEton Pharmaceuticals Inc.

$50.72-0.45%75

SEPNSepterna, Inc.

$47.88+9.57%46

AGIOAgios Pharmaceuticals Inc.

$31.38+0.58%40

GYREGyre Therapeutics Inc.

$4.44+0.00%18

SPRYArs Pharmaceuticals Inc

$3.05+0.00%40

Held by ETFs

LFCR is in 5 US ETFs. The largest of them, with LFCR's weight in each:

Lifecore Biomedical (LFCR) in two numbers

Quality score: 0/100; Best check: revenue growth, -13.6%.; Quality
Dividend: None; Last paid in 2012, nothing since.; Dividends

Questions about Lifecore Biomedical

Is Lifecore Biomedical a high-quality business?

Lifecore Biomedical scores 0 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 5 checks computed from SEC filings. Its best check is revenue growth at -13.6%. The Quality tab shows every check against its target.

Does Lifecore Biomedical (LFCR) pay a dividend?

No. Lifecore Biomedical (LFCR) does not currently pay a dividend. The last payment in our data was in 2012, and nothing has been paid since. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 29 Jul 2026 (period ending 30 Jun 2026), SEC. Price: last close 4 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in LFCR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing LFCR

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.